HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unique effects of 24,25-dihydroxyvitamin D3 in uremic patients.

Abstract
The effects of 24,25-dihydroxyvitamin D3 (24,25[OH]2D3), given orally for 7-10 days at doses of 2 and 4 microgram/day, were evaluated in patients with advanced renal failure. There was a significant fall in serum Ca and a rise in alkaline phosphatase; both returned to pretreatment levels 2 weeks after cessation of therapy. There was no change in intestinal absorption of 47Ca. These observations are significantly different from those observed during treatment with 1,25(OH)2D3 or 25(OH)D3, indicating that different vitamin D sterols can clearly exert different biologic effects.
AuthorsF Llach, A S Brickman, J W Coburn
JournalContributions to nephrology (Contrib Nephrol) Vol. 18 Pg. 212-7 ( 1980) ISSN: 0302-5144 [Print] Switzerland
PMID7353377 (Publication Type: Journal Article)
Chemical References
  • Dihydroxycholecalciferols
  • Hydroxycholecalciferols
  • Phosphates
  • Alkaline Phosphatase
  • Calcium
Topics
  • Alkaline Phosphatase (blood)
  • Animals
  • Calcium (blood, metabolism)
  • Dihydroxycholecalciferols
  • Hydroxycholecalciferols
  • Intestinal Absorption (drug effects)
  • Kidney Failure, Chronic (metabolism)
  • Phosphates (blood)
  • Renal Dialysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: